Why Do Our Nerves Respond Differently to Touch, Temperature, and Pressure?
A new 2026 neuroscience discovery reveals how a protein called CRELD1 helps regulate sensory-neuron excitability across touch, temperature, pain, and itch
Biotech International Institute (BII)
The Brain's Unanswered Questions — Wednesday, November 4, 2026
Introduction: How Does Your Nervous System Know the Difference?
Imagine lightly brushing your hand against a piece of fabric.
Now imagine touching something cold.
Then consider the sudden sensation of stepping on a sharp object.
Each experience produces a different response.
A gentle touch might barely attract your attention.
Cold temperatures may cause you to withdraw your hand or seek warmth.
A sharp object can trigger an immediate protective reaction.
But how does your nervous system distinguish these experiences?
And what determines how strongly your sensory neurons respond?
For decades, neuroscience has investigated the specialized receptors and nerve cells that detect mechanical force, temperature, potentially damaging stimuli, and chemical irritation.
Researchers have identified molecular sensors involved in these processes.
But an important question remains.
After a sensory stimulus is detected, what regulates whether the electrical signal is strong enough to travel through the nervous system?
On October 22, 2026, researchers published a study in Nature Neuroscience titled:
Behavioral genomics identifies Creld1 as a cross-modal regulator of somatosensation.
The investigators identified a protein called CRELD1 that helps regulate the electrical excitability of sensory neurons.
The findings were particularly surprising because the protein influenced several different sensory modalities.
In mouse experiments, removing CRELD1 weakened responses to touch, temperature, pain-related stimulation, and itch.
Increasing CRELD1 expression produced stronger responses to certain tactile and thermal stimuli.
The research suggests that a single molecular regulator can influence multiple sensory systems by changing how easily neurons generate electrical impulses.
For Biotech International Institute, this discovery highlights a fundamental principle of neurological research.
Understanding a sensory experience requires investigating both the molecules that detect a stimulus and the cellular mechanisms that control how the resulting signal is transmitted.
---
1. What Is Somatosensation?
Somatosensation refers to the nervous system's ability to detect and process information from the body.
It includes several related but distinct sensory functions.
Touch: Detecting contact, pressure, vibration, and aspects of surface texture.
Temperature: Detecting warming, cooling, heat, and cold.
Nociception: Detecting potentially tissue-damaging mechanical, thermal, or chemical stimuli.
Itch: Detecting stimuli that can provoke scratching behavior.
Proprioception: Detecting the position and movement of the body.
These sensory functions help us interact with our environment.
They also play important protective roles.
The ability to detect damaging heat, for example, can prevent serious injury.
The sensation of pressure can help us adjust our grip on an object.
Proprioception contributes to movement without requiring constant visual monitoring.
Although these functions differ, they rely on overlapping principles of cellular signaling.
Specialized sensory neurons detect stimuli and convert information into electrical activity.
The nervous system then processes that activity through spinal, brainstem, and cortical networks.
2. Meet the Dorsal Root Ganglion Neurons
Many sensory signals from the body begin in neurons whose cell bodies are located in structures called dorsal root ganglia, or DRGs.
These clusters sit near the spinal cord.
DRG neurons are primary sensory neurons.
Their peripheral branches extend into tissues such as skin, muscles, and joints.
Their central branches transmit information toward the spinal cord.
Different DRG neuron populations express different molecular receptors and ion channels.
Some are especially important for detecting gentle mechanical stimulation.
Others respond to potentially damaging heat or chemical irritants.
Still others contribute to itch, cold sensation, or body-position sensing.
However, the distinction among sensory modalities is not always absolute.
Individual neuronal populations may respond to more than one stimulus category.
The 2026 CRELD1 study examined how molecular regulation within DRG neurons contributes to this broader sensory system.
3. First the Stimulus Must Be Detected
One of the most important advances in sensory neuroscience has been the identification of receptors that detect different physical stimuli.
An especially important example is PIEZO2.
PIEZO2 is a mechanically activated ion channel involved in detecting gentle touch and proprioceptive information.
Mechanical force changes the channel's activity.
This produces electrical changes that can contribute to sensory-neuron activation.
Temperature-sensitive pathways involve several additional molecular systems.
TRPV1 is particularly well studied for its responses to capsaicin and noxious heat.
TRPM8 contributes to cool-temperature sensing and responses to substances such as menthol.
Other channels and sensory mechanisms contribute to responses across a wider range of temperatures.
These molecules help explain how different forms of stimulation can be detected.
But stimulus detection is only the beginning.
A sensory neuron must also generate and propagate an electrical signal.
That is where the new CRELD1 research becomes particularly interesting.
4. Detecting a Sensation Is Different From Transmitting It
Imagine a sensory receptor successfully detects pressure against the skin.
That detection changes electrical activity in the nerve ending.
However, the signal still needs to trigger action potentials.
An action potential is a rapidly propagating electrical event that allows neurons to communicate over long distances.
The ability to generate action potentials depends heavily on ion channels.
Among the most important are voltage-gated sodium channels.
These channels open in response to changes in the electrical potential across the cell membrane.
The resulting sodium movement contributes to the rapid electrical activation characteristic of an action potential.
The neuron's excitability influences how easily it fires.
A highly excitable neuron may respond to relatively weak stimulation.
A less excitable neuron may require a stronger stimulus.
This means sensory intensity can be influenced by mechanisms beyond the original stimulus detector.
5. The October 2026 Discovery: A New Sensory Regulator
Researchers Yan Jiang, Wanru Huang, Hailong Yao, and colleagues, led by Bailong Xiao, investigated the molecular biology of sensory neurons.
Their study used a genetic screening approach in mice.
The researchers developed a postnatal CRISPR–Cas9 system to disrupt selected genes expressed in DRG neurons.
Rather than relying exclusively on changes introduced during embryonic development, their platform allowed them to investigate gene function after birth.
They first examined genes with established sensory roles.
These included:
- Piezo2
- Trpv1
- Scn9a
Scn9a encodes the voltage-gated sodium channel Naᵥ1.7, an important component of peripheral sensory-neuron excitability.
After validating their approach, researchers screened 20 selected genes.
One gene stood out.
Creld1.
Removing Creld1 altered responses across multiple types of sensory stimulation.
This suggested that CRELD1 might function as a broad regulator rather than as a receptor dedicated to a single sensation.
6. What Happened When Scientists Removed CRELD1?
The researchers used two distinct genetic approaches to investigate CRELD1.
One involved CRISPR-mediated disruption after birth.
The other involved inducible genetic deletion in DRG neurons.
Both approaches supported the importance of CRELD1 for normal somatosensory responses.
Mice lacking CRELD1 in relevant sensory neurons exhibited reduced behavioral responses to several stimuli.
These included light touch, mechanically painful stimulation, heat, cold, and itch-provoking conditions.
For example, animals showed altered withdrawal responses during mechanical testing.
They also demonstrated delayed or weakened responses under particular thermal conditions.
These findings indicated broad sensory impairment.
Importantly, the study did not establish that the mice had lost every sensation.
The tests measured specific behavioral responses under defined experimental conditions.
And the effects occurred in genetically modified animals, not in human patients receiving a treatment.
Nevertheless, the consistency across different tests made CRELD1 a compelling candidate for further investigation.
7. Why Could One Protein Influence So Many Different Sensations?
This was perhaps the most important mechanistic question raised by the study.
Touch, temperature, pain-related stimulation, and itch involve different molecular detection systems.
How could disrupting one protein influence all of them?
The researchers found evidence that CRELD1 regulates voltage-gated sodium channels.
These channels are important for generating electrical impulses in sensory neurons.
When CRELD1 function was disrupted, sodium currents were reduced.
The neurons became less excitable.
They required stronger stimulation to produce action potentials and generated fewer impulses under experimental conditions.
This offers an explanation for the broader behavioral effects.
CRELD1 does not need to detect every stimulus directly.
Instead, it can influence the electrical machinery that many sensory neurons use after their receptors have responded.
A shared regulator of excitability can affect several sensory modalities even when their initial detectors are different.
That distinction makes this discovery particularly relevant to the broader science of pain signaling.
8. CRELD1 and Voltage-Gated Sodium Channels
Voltage-gated sodium channels belong to a family of related proteins.
Different members of this family contribute to distinct physiological functions.
Some are particularly important for peripheral sensory signaling.
Others have major roles in cardiac or central nervous system activity.
This diversity matters for neurological drug discovery.
A molecule that changes one sodium-channel function may not have the same effects on another.
Selectivity can therefore be critical.
The CRELD1 study identified interactions between the protein and voltage-gated sodium channels in experimental systems.
The researchers used biochemical and electrophysiological techniques to examine these relationships.
Their findings indicated that CRELD1 acts as an auxiliary regulator of channel function.
This suggests that channel activity may be influenced not only by the channel's own structure, but also by associated proteins.
These interacting proteins could become important subjects of future research.
However, an association between proteins does not automatically establish a safe therapeutic target.
Researchers must understand the biological consequences of changing those interactions.
9. Why Naᵥ1.7 Is Important to Pain Research
One sodium channel attracting substantial scientific interest is Naᵥ1.7.
It is encoded by SCN9A.
Human genetic studies have demonstrated that variants affecting Naᵥ1.7 function can produce profound changes in pain perception.
Certain loss-of-function variants are associated with congenital insensitivity to pain.
Other variants can contribute to inherited pain disorders.
This provides strong human genetic evidence that sodium-channel function is important for sensory physiology.
But the relationship is complex.
Completely eliminating pain perception would not necessarily be desirable.
Pain plays a critical protective role.
A person who cannot recognize tissue damage may experience injuries without appropriate warning.
This helps explain why pain research often investigates ways to reduce pathological signaling while preserving necessary protective sensations.
The CRELD1 study adds another level to this problem.
It suggests that associated regulators may influence sodium-channel activity and sensory-neuron excitability.
But the findings do not establish that modifying CRELD1 would provide selective pain relief.
10. What Happened When CRELD1 Was Increased?
The investigators also examined whether increasing CRELD1 expression would produce the opposite effect.
In mouse experiments, elevated CRELD1 expression enhanced certain tactile and temperature-related responses.
Electrophysiological measurements also supported a role in strengthening sodium-channel-associated activity.
Together with the gene-deletion experiments, these findings offered evidence that CRELD1 can regulate sensory-neuron excitability in more than one direction.
Reducing CRELD1 decreased responsiveness under several experimental conditions.
Increasing it enhanced selected sensory responses.
This provides stronger mechanistic evidence than a simple observation that CRELD1 is present in sensory neurons.
However, the responses were not identical across every sensory modality or assay.
The precise effects depended on the experimental conditions.
11. Do Human Sensory Neurons Work the Same Way?
This is one of the most important unanswered questions.
The central behavioral findings came from mice.
The researchers also investigated human CRELD1 and its relationship with human sodium-channel proteins in cultured cells.
Their experiments revealed an important complication.
Different human CRELD1 isoforms did not produce identical effects on Naᵥ1.7.
One tested isoform enhanced sodium-channel activity, whereas another did not show the same effect.
An isoform is a variant form of a protein that can arise through differences in how genetic information is processed.
Isoforms can have different biological properties.
This finding demonstrates why translation from mice to humans requires careful investigation.
Researchers still need to understand which CRELD1 forms are expressed in different human sensory-neuron populations.
They must also determine whether modifying CRELD1 in human tissue would reproduce the desired physiological effects without impairing necessary sensory functions.
The study offers promising mechanistic evidence.
It does not establish a clinically validated human intervention.
12. Touch, Pain, and Pressure Are Not Identical
Although the title of today's article concerns touch, temperature, and pressure, these concepts require careful distinction.
Gentle pressure against the skin may activate low-threshold mechanosensory pathways.
Potentially damaging pressure may activate nociceptive systems.
The subjective experience of pain involves further processing across spinal and brain networks.
Therefore, a stronger sensory-neuron response is not always equivalent to a stronger conscious sensation.
Similarly, reduced withdrawal behavior in a mouse does not prove complete elimination of pain experience.
Behavioral testing provides experimentally measurable indicators of sensory function.
But conscious pain involves additional complexity.
This is why translational research requires appropriately selected endpoints.
An investigator studying receptor activity is measuring something different from an investigator studying neuronal firing.
And both are measuring something different from a clinician evaluating pain severity in a patient.
13. Why Itch Is an Important Part of the Discovery
Itch is often discussed separately from pain.
Although the two systems share aspects of sensory biology, itch involves distinct cellular pathways and behavioral outcomes.
Certain chemical mediators activate specialized peripheral sensory systems associated with itching.
These signals can produce scratching behavior.
The CRELD1 findings are particularly interesting because the protein influenced responses to itch-provoking stimuli as well as other somatosensory modalities.
This supports the idea that common electrical signaling machinery can contribute to different sensory experiences.
It also raises a caution.
A broadly acting intervention affecting sensory-neuron excitability might change several sensations at once.
That could potentially include both desired and unwanted effects.
Understanding these tradeoffs would be essential in any future therapeutic research.
14. Could This Discovery Change Chronic Pain Research?
Chronic pain is not simply acute pain that continues for a longer period.
It can involve lasting changes in peripheral neurons, spinal processing, central networks, immune signaling, and other biological systems.
In some conditions, sensory neurons become more excitable.
This can contribute to heightened responsiveness.
However, not every chronic pain condition involves the same mechanism.
A broad regulator such as CRELD1 could help scientists investigate how sodium-channel function affects peripheral sensory signaling.
Potential research questions include whether CRELD1 contributes to abnormal excitability in particular disease models and whether its expression changes following nerve injury.
But the October 2026 study did not demonstrate that targeting CRELD1 treats chronic pain.
It did not establish efficacy in humans.
And a general reduction in sensory responses could impair protective touch or temperature perception.
The most meaningful future research would need to distinguish relief of pathological signaling from loss of normal sensory function.
15. Why This Matters for Non-Opioid Research
The search for better approaches to difficult-to-treat pain conditions has increased interest in mechanisms beyond conventional opioid signaling.
Researchers are studying ion channels, neuroimmune interactions, receptor pharmacology, and mechanisms of neuronal excitability.
Voltage-gated sodium channels are particularly relevant because of their direct involvement in action-potential generation.
The discovery of an auxiliary protein involved in sodium-channel regulation expands the molecular questions available for investigation.
Instead of examining only a channel's active site or electrical conductance, scientists can investigate proteins that influence its function.
But an experimentally interesting mechanism is not the same as an established drug target.
Researchers must consider safety, tissue distribution, specificity, exposure, reversibility, and the consequences of altering normal sensation.
The discovery provides a direction for preclinical research, not a proven non-opioid treatment.
16. The Broader Value of Behavioral Genomics
The study also introduced an experimental platform.
Using postnatal gene disruption and sensory behavioral testing, researchers could screen candidate genes for their roles in sensory function.
This matters because sensory biology involves many molecular components that remain incompletely understood.
Traditional studies often focus on genes already suspected of participating in a pathway.
Screening approaches can reveal unexpected regulators.
However, the platform itself requires appropriate controls.
Gene disruption must be verified.
Potential unintended effects need to be considered.
Researchers must distinguish changes in sensory function from changes in movement, general health, or behavior.
Independent replication also remains important.
The new study demonstrates how combining genetic approaches with cellular electrophysiology, biochemical analyses, and behavior can generate a more informative mechanistic picture.
17. What This Means for Biotech International Institute
At Biotech International Institute, our research portfolio includes investigational programs addressing neurological resilience, neural adaptation, and pain-related biology.
The CRELD1 discovery is scientifically relevant because it demonstrates the importance of understanding cellular excitability when investigating sensory function.
NeuroRelief-P™
Our research-stage precision-peptide direction explores hypotheses involving chronic and neuropathic pain modulation.
The CRELD1 study highlights the value of examining neuronal excitability, voltage-gated sodium-channel function, and measurable sensory endpoints.
However, BII has not established that NeuroRelief-P™ interacts with CRELD1, modifies Naᵥ1.7, or produces analgesic effects.
Any relationship would require direct biochemical and functional testing.
NeuroRegen-P™
Our regenerative-signaling peptide direction involves research questions concerning axonal growth, neural repair, and functional recovery.
The new findings emphasize that the presence of sensory neurons alone does not establish normal sensory function.
Functional electrophysiology and appropriate physiological measurements would be important in evaluating regenerative hypotheses.
No effect on CRELD1 or sensory recovery has been demonstrated for NeuroRegen-P™.
Neurophorol™
Our cannabinoid-inspired, CB2-oriented small-molecule program focuses on receptor pharmacology and neuroimmune-related mechanisms.
The CRELD1 study illustrates a complementary but distinct area of sensory biology.
BII has not demonstrated any interaction between Neurophorol™ and CRELD1 or voltage-gated sodium channels.
These distinctions are important.
Scientific relevance should not be confused with experimental validation of a particular BII candidate.
18. What Would Responsible Validation Look Like?
If a research program proposed to investigate sensory-neuron excitability, several types of evidence could become relevant.
Molecular characterization
Does the investigational material have a defined chemical or biological identity, adequate purity, and reproducible properties?
Target engagement
Does it interact with the intended target under appropriate experimental conditions?
Electrophysiology
Does it change ion-channel activity, neuronal firing thresholds, or action-potential patterns?
Cellular selectivity
Are its effects confined to relevant sensory-neuron populations, or does it also influence other excitable tissues?
Functional endpoints
Do measurable changes in sensory signaling correspond to appropriate changes in experimental function?
Safety
Could the intervention impair protective sensation, motor function, cardiac activity, or other essential physiological processes?
Translational relevance
Do the findings reproduce in human-relevant systems?
These are examples of questions that may guide research design.
They are not descriptions of completed BII experiments.
19. What Scientists Still Need to Discover
The CRELD1 study raises several important questions.
How does CRELD1 regulate different sodium-channel isoforms?
Are its effects similar across all sensory-neuron populations?
Which human CRELD1 isoforms are most important for normal sensory function?
Does CRELD1 expression change following nerve injury?
Could abnormal CRELD1 regulation contribute to particular sensory disorders?
Can researchers alter pathological excitability without impairing necessary protective sensations?
Would interventions affecting CRELD1 cause unintended effects in other tissues?
And can the mechanism be reproduced consistently across relevant human experimental systems?
These questions will determine whether CRELD1 becomes primarily a valuable mechanistic research tool or eventually informs a therapeutically useful approach.
Closing Thought: Sensation Depends on More Than the Stimulus
When we touch an object, feel cold, or experience pain, the nervous system performs a remarkable sequence of biological events.
Specialized molecules detect changes in the environment.
Sensory neurons transform those changes into electrical signals.
Voltage-gated ion channels help generate and transmit impulses.
Spinal and brain networks process the incoming information.
And the resulting perception depends on interactions across multiple levels of the nervous system.
The October 2026 discovery adds an important piece to this picture.
A protein called CRELD1 appears to influence how sensory neurons respond across several different stimulus types.
Its activity helps regulate voltage-gated sodium-channel function and neuronal excitability.
The findings challenge an overly simplified view in which each sensory experience depends exclusively on its own isolated molecular pathway.
Different sensations can share important regulatory mechanisms.
For future neuroscience, that presents both opportunity and responsibility.
Better understanding of sensory-neuron excitability may support more precise scientific questions.
But preserving normal protective sensations remains essential.
For Biotech International Institute, the message is consistent with our research philosophy.
The goal is not simply to identify molecules that change biological signals. It is to understand which signals matter, how they function, and whether modifying them can be demonstrated to be safe and beneficial.
That is how experimental discoveries become meaningful scientific evidence.
Research-stage. Built for validation.
Mechanism first. Validation always.
Biotech International Institute
Science. People. Communities. A Healthier Tomorrow.
---
Scientific References
1. Jiang, Y., Huang, W., Yao, H., et al. (2026).
Behavioral genomics identifies Creld1 as a cross-modal regulator of somatosensation.
Nature Neuroscience. Published October 22, 2026.
2. Rohacs, T. (2026).
Regulation of somatosensory ion channels activated by mechanical stimuli.
npj Biological Physics and Mechanics, 3, Article 15.
3. National Library of Medicine — PubMed.
Behavioral genomics identifies Creld1 as a cross-modal regulator of somatosensation.
PMID: 42918863.
Research disclosure: This article discusses independent published neuroscience research. The central CRELD1 behavioral findings were obtained in mice, with additional human-protein studies conducted in experimental cellular systems. No clinical efficacy has been established. NeuroRelief-P™, NeuroRegen-P™, Neurophorol™, and other BII programs remain research-stage; no direct activity involving CRELD1, sodium-channel regulation, analgesia, or sensory recovery has been demonstrated for these candidates.
